Atlas Trials

Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx

Clinical trial NCT00004227 · TERMINATED

Trial details

NCT number
NCT00004227
Sponsor
University of Alabama at Birmingham
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
1999-04-01
Primary completion
2007-03-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.